Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...